Harry A.
Director, Process Development @Editas Medicine
Signup · Get unlimited contacts
WORK HISTORY
Director, Process Development @Editas Medicine
Cambridge, MA, US
Provided scientific, tactical, and strategic leadership to develop workflows suitable for clinical and commercial manufacturing for CRISPR-based engineered cell medicines within Editas’ ex vivo product portfolio Supported GMP production and release of 300+ autologous, EDIT-301 drug substance intermediate, and 60+ drug product (DP) batches used in Ruby (Pivotal) and EdiThal (Phase 1) trials achieving >98% manufacturing success rate
EDUCATION
Massachusetts Institute of Technology
Doctor of Philosophy (PhD), Chemical Engineering
Carnegie Mellon University
Bachelor of Science (B.S.), Chemical Engineering
SKILLS
ABOUT HARRY A.
Strategic technical leader solving complex manufacturing challenges and enabling reliable supply of innovative therapies
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.